Siwei Xia

819 total citations · 1 hit paper
30 papers, 537 citations indexed

About

Siwei Xia is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Siwei Xia has authored 30 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 9 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Siwei Xia's work include Liver Disease Diagnosis and Treatment (9 papers), Liver physiology and pathology (6 papers) and Autophagy in Disease and Therapy (5 papers). Siwei Xia is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver physiology and pathology (6 papers) and Autophagy in Disease and Therapy (5 papers). Siwei Xia collaborates with scholars based in China, United States and Hong Kong. Siwei Xia's co-authors include Shizhong Zheng, Zili Zhang, Jiangjuan Shao, Zhanghao Li, Sumin Sun, Feixia Wang, Baoyu Liang, Ying Su, Xuefen Xu and Shijun Wang and has published in prestigious journals such as Hepatology, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Siwei Xia

29 papers receiving 537 citations

Hit Papers

Canonical Wnt signaling promotes HSC glycolysis and liver... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siwei Xia China 14 222 184 96 92 73 30 537
Saijun Fan China 11 257 1.2× 120 0.7× 75 0.8× 61 0.7× 62 0.8× 32 581
Qianqian Tu China 9 180 0.8× 300 1.6× 75 0.8× 102 1.1× 50 0.7× 12 640
Hongyao Liu China 11 191 0.9× 133 0.7× 53 0.6× 112 1.2× 156 2.1× 30 551
Yitao Ou China 13 300 1.4× 145 0.8× 70 0.7× 117 1.3× 32 0.4× 19 603
Wang‐Xiang Xu China 12 475 2.1× 122 0.7× 111 1.2× 111 1.2× 36 0.5× 23 755
Youming Ding China 14 246 1.1× 88 0.5× 116 1.2× 67 0.7× 103 1.4× 39 581
Pengcheng Luo China 17 377 1.7× 206 1.1× 183 1.9× 37 0.4× 54 0.7× 26 775
Hongjiao Xiang China 13 285 1.3× 110 0.6× 97 1.0× 30 0.3× 42 0.6× 21 537
Zixiong Zhou China 13 211 1.0× 200 1.1× 162 1.7× 86 0.9× 174 2.4× 31 598

Countries citing papers authored by Siwei Xia

Since Specialization
Citations

This map shows the geographic impact of Siwei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siwei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siwei Xia more than expected).

Fields of papers citing papers by Siwei Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siwei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siwei Xia. The network helps show where Siwei Xia may publish in the future.

Co-authorship network of co-authors of Siwei Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Siwei Xia. A scholar is included among the top collaborators of Siwei Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siwei Xia. Siwei Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Weidong, Meihui Wang, Siwei Xia, et al.. (2025). Induction of UBQLN1‐mediated PGC1α stability by isoliensinine overcame hypoxia‐induced resistance in liver cancer cells. BioFactors. 51(2). e70008–e70008. 1 indexed citations
3.
Xu, Xuefen, Yujia Li, Sumin Sun, et al.. (2024). Inhibition of TFAM-Mediated Mitophagy by Oroxylin A Restored Sorafenib Sensitivity Under Hypoxia Conditions in HepG2 Cells. Pharmaceuticals. 17(12). 1727–1727. 1 indexed citations
4.
Xia, Siwei, et al.. (2024). Regulated Cell Death of Alveolar Macrophages in Acute Lung Inflammation: Current Knowledge and Perspectives. Journal of Inflammation Research. Volume 17. 11419–11436. 4 indexed citations
5.
Xia, Siwei, et al.. (2024). Fine-grained Abnormality Detection and Natural Language Description of Medical CT Images Using Large Language Models. International Journal of Innovative Research in Computer Science & Technology. 12(6). 52–62. 2 indexed citations
6.
Xia, Siwei, et al.. (2024). The interplay between mitophagy and mitochondrial ROS in acute lung injury. Mitochondrion. 78. 101920–101920. 11 indexed citations
8.
Chen, Xiaomei, Feixia Wang, Siwei Xia, et al.. (2023). Yi-Qi-Jian-Pi formula ameliorates immune function in acute-on-chronic liver failure by upregulating autophagy and mitochondrial biogenesis in CD8+ T lymphocytes. Journal of Ethnopharmacology. 308. 116276–116276. 5 indexed citations
9.
Xu, Xuefen, Siwei Xia, Li Chen, et al.. (2023). Induction of DNMT1-dependent demethylation of SHP-1 by the natural flavonoid compound Baicalein overcame Imatinib-resistance in CML CD34+ cells. Cell Communication and Signaling. 21(1). 47–47. 1 indexed citations
10.
Chen, Li, Siwei Xia, Feixia Wang, et al.. (2023). m6A methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis. Pharmacological Research. 189. 106704–106704. 18 indexed citations
11.
Xia, Siwei, Li Chen, Ting Yang, et al.. (2023). Blockade of KLF5/LDH—A feedback loop contributes to Curcumol inhibition of sinusoidal endothelial cell glycolysis and mitigation of liver fibrosis. Phytomedicine. 114. 154759–154759. 18 indexed citations
12.
Sun, Sumin, Zhanghao Li, Jun Kai, et al.. (2022). Modification of lysine deacetylation regulates curcumol‐induced necroptosis through autophagy in hepatic stellate cells. Phytotherapy Research. 36(6). 2660–2676. 14 indexed citations
13.
Chen, Li, Siwei Xia, Shuqi Wang, et al.. (2022). Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 19 indexed citations
14.
Sun, Sumin, Zhanghao Li, Ying Su, et al.. (2022). Curcumol alleviates liver fibrosis by inducing endoplasmic reticulum stress-mediated necroptosis of hepatic stellate cells through Sirt1/NICD pathway. PeerJ. 10. e13376–e13376. 28 indexed citations
15.
Xia, Siwei, Zhimin Wang, Li Chen, et al.. (2021). Dihydroartemisinin regulates lipid droplet metabolism in hepatic stellate cells by inhibiting lncRNA-H19-induced AMPK signal. Biochemical Pharmacology. 192. 114730–114730. 17 indexed citations
16.
Su, Ying, Chun Jin, Zhanghao Li, et al.. (2021). Dihydroartemisinin Induces Ferroptosis in HCC by Promoting the Formation of PEBP1/15‐LO. Oxidative Medicine and Cellular Longevity. 2021(1). 3456725–3456725. 42 indexed citations
17.
Fei, Ran, Siwei Xia, Jixin Hou, et al.. (2021). Feasibility and effectiveness of a single-catheter approach for adrenal vein sampling in patients with primary aldosteronism. BMC Endocrine Disorders. 21(1). 22–22. 9 indexed citations
18.
Wang, Zhimin, Siwei Xia, Tian Zhang, et al.. (2020). LncRNA-H19 induces hepatic stellate cell activation via upregulating alcohol dehydrogenase III-mediated retinoic acid signals. International Immunopharmacology. 84. 106470–106470. 10 indexed citations
19.
Li, Zhanghao, Feixia Wang, Baoyu Liang, et al.. (2020). Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduction and Targeted Therapy. 5(1). 280–280. 84 indexed citations
20.
Xia, Siwei, Zhimin Wang, Sumin Sun, et al.. (2020). Endoplasmic reticulum stress and protein degradation in chronic liver disease. Pharmacological Research. 161. 105218–105218. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026